Loading stock data…
The Cooper Companies, Inc. (COO)
$67.69-1.90 (-2.73%)
Market ClosedLast close Sep 8
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
The Cooper Companies, Inc. in the Healthcare sector is trading at $67.69 with a market capitalization of $14.5B. Wall Street consensus targets $81.50 (14 analysts), implying a +20.4% move over the next 12 months. The stock is currently 25% below its 52-week high of $89.83, remaining 7.7% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the safe zone. Risk note: RSI 20 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +20.4% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Oversold momentum (RSI 20) — potential for technical mean-reversion
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $1.08B↑ | $1.02B↓ | $1.07B↑ | $1.06B↑ | $1.00B |
| Gross Profit | $735.40M↑ | $695.20M↑ | $650.80M↓ | $692.00M↑ | $679.10M |
| Operating Income | -$31.00M↓ | $212.80M↑ | $140.40M↓ | $175.70M↓ | $184.80M |
| Net Income | -$77.90M↓ | $130.80M↑ | $84.60M↓ | $98.30M↑ | $87.70M |
Peer Comparison
JNJUNHPFE
Fundamentals
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifo...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$14.47B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
62.88
Beta
Defensive asset. Lower volatility than the S&P 500.
0.84
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
2.86%
Volume
Today's trading volume
2.92M
Recent News
CooperCompanies (COO) To Report Earnings Tomorrow: Here Is What To Expect
Medical device company CooperCompanies (NASDAQ:COO) will be reporting earnings this Wednesday after market close. Here’s what to expect.
Countdown to The Cooper Companies (COO) Q3 Earnings: Wall Street Forecasts for Key Metrics
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for The Cooper Companies (COO), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended July 2026.
1 Mid-Cap Stock with Impressive Fundamentals and 2 Facing Challenges
Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with competition, ranging from giants with vast resources to agile upstarts eager to disrupt the status quo.
Are Wall Street Analysts Bullish on Cooper Companies Stock?
Cooper Companies has underperformed the broader market over the past year, and analysts remain somewhat optimistic about the stock’s prospects.
1 Healthcare Stock to Target This Week and 2 Facing Headwinds
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 28.9% gain over the past six months, beating the S&P 500 by 18 percentage points.